ClinicalTrials.gg
Sign In

Drug

TG103 clinical trials

Also written TG103.

studies test it
11
open now
0
in phase 3
3
first study started
2019

How studies write it

Studies that test it under each name

Name

TG103 22.5 mg
3
TG103 15 mg
2

Development codes

TG103
5

Studies by the year they started

11 studies that test it; most in 2021 (4)

Studies that test TG103, by start year
YearStudies
20191
20214
20222
20231
20243

By phase

A phase 1/2 study counts in both.

Phase 1
4
Phase 2
4
Phase 3
3

What it is tested for

Each study’s main condition, where its own words name it.

Diabetes Mellitus, Type 2
5
Obesity
3

Who runs them

Industry 11 · Other 0

CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. (9) · CSPC ZhongQi Pharmaceutical Technology Co., Ltd. (2)

Often tested with

Tested in the same studies.

Dulaglutide (1)

Studies

Open first, then newest update. How each study uses TG103 is read from its arms, and is right about nine times in ten.

Testing it · 11